This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Multiple Myeloma; Neoplasm, Residual
|
|
has minor subject area list
|
Clinical Trials as Topic; Diagnostic Imaging; Disease Management; Drug Collateral Sensitivity; Global Health; Humans; Molecular Diagnostic Techniques; Neoplastic Cells, Circulating; Outcome Assessment, Health Care; Population Surveillance; Reproducibility of Results; Smoldering Multiple Myeloma; Time Factors
|
|
information resource reference
|
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia. 2021 01; 35(1):18-30.
|
|
label
|
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.
|